文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

微生物组崩溃、致病生物组出现与脓毒症免疫病理

Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论该文提出脓毒症新框架:宿主微生物组丧失与医疗获得/适应致病生物组出现,驱动适应不良免疫反应与难治性器官功能障碍。

该文指出脓毒症定义虽经修订,但仍难以界定,传统上被框定为炎症紊乱。作者提出应将脓毒症理解为一个由微生物群、致病生物群与宿主免疫细胞相互竞争导致失去弹性与难治性器官功能障碍的过程。作者质疑非感染性脓毒症概念,理由是危重患者不存在无菌状态。作者提出脓毒症病理生理新 vision:宿主微生物组必然丧失,出现由「医疗获得与医疗适应致病生物群」构成的致病生物组,危重患者是被致病生物群定植、动态表达涌现特性并驱动适应不良免疫反应的宿主。

要点

  • 作者提出脓毒症应理解为微生物群、致病生物群与宿主免疫细胞相互竞争导致失去弹性与难治性器官功能障碍。
  • 作者质疑非感染性脓毒症概念,理由是危重患者不存在无菌状态。
  • 作者提出脓毒症新框架包含宿主微生物组必然丧失与「医疗获得与医疗适应致病生物群」构成的致病生物组出现。
  • 在该框架下,危重患者被视为被致病生物群定植的宿主,致病生物群动态表达涌现特性,驱动并受驱动于适应不良免疫反应。

证据类型、等级与局限

  • 证据类型:综述(原文为概念性论述,未报告系统检索或证据分级)。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The definition of sepsis has been recently modified to accommodate emerging knowledge in the field, while at the same time being recognized as challenging, if not impossible, to define. Here, we seek to clarify the current understanding of sepsis as one that has been typically framed as a disorder of inflammation to one in which the competing interests of the microbiota, pathobiota, and host immune cells lead to loss of resilience and nonresolving organ dysfunction. Here, we challenge the existence of the idea of noninfectious sepsis given that critically ill humans never exist in a germ-free state. Finally, we propose a new vision of the pathophysiology of sepsis that includes the invariable loss of the host's microbiome with the emergence of a pathobiome consisting of both "healthcare-acquired and healthcare-adapted pathobiota." Under this framework, the critically ill patient is viewed as a host colonized by pathobiota dynamically expressing emergent properties which drive, and are driven by, a pathoadaptive immune response.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Alverdy JC, Krezalek MA. Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis. Crit Care Med. 2017. PMID: 28098630. doi:10.1097/CCM.0000000000002172

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。